Amgen (AMGN)
(Delayed Data from NSDQ)
$298.43 USD
+6.43 (2.20%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $298.50 +0.07 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Amgen Inc. has a market cap of $157.20B, which represents its share price of $292.00 multiplied by its outstanding shares number of 538.36M. As a large-cap company, AMGN's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AMGN 298.43 +6.43(2.20%)
Will AMGN be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for AMGN
Demographic Megatrend: Stocks Poised to Benefit From Global Aging
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Amgen's Q3 Earnings in the Cards: Here's What to Expect
Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for
Other News for AMGN
Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week
Palantir, Qualcomm Set To Report Earnings
Crossed Above 20 Day Moving Average appears for AMGN after 2.2% move
More than 80% of companies report EPS wins this week: Earnings Scorecard
AbbVie: Why Q3 Confirms Its Immunology Dominance